QGEN - Qiagen NV
Close
45.71
0.030 0.066%
Share volume: 1,668,925
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$45.68
0.03
0.07%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-03-13 | 2023-05-05 | 2023-08-10 | 2023-11-01 | 2024-03-11 | 2024-05-01 | 2024-08-02 | |
| Assets | |||||||||
| Total Assets | 6.517 B | 6.288 B | 6.279 B | 6.347 B | 5.907 B | 6.115 B | 5.806 B | 5.585 B | |
| Current Assets | 2.756 B | 2.394 B | 2.251 B | 2.311 B | 1.962 B | 2.148 B | 1.891 B | 1.830 B | |
| Inventories | 323.472 M | 357.960 M | 380.824 M | 391.989 M | 399.207 M | 398.385 M | 401.745 M | 321.750 M | |
| Other Current Assets | 234.082 M | 200.502 M | 265.909 M | 274.939 M | 220.715 M | 123.034 M | 251.992 M | 262.489 M | |
| Short Term Investments | 234.082 M | 200.502 M | 265.909 M | 274.939 M | 220.715 M | 123.034 M | 251.992 M | 262.489 M | |
| Total Receivables | 310.975 M | 396.141 M | 317.244 M | 312.599 M | 326.690 M | 480.693 M | 343.892 M | 355.300 M | |
| Current Cash | 1.887 B | 1.418 B | 1.287 B | 1.332 B | 1.016 B | 1.058 B | 893.133 M | 890.240 M | |
| Total Non-current Assets | 3.761 B | 3.894 B | 4.028 B | 4.036 B | 3.944 B | 3.968 B | 3.915 B | 3.755 B | |
| Property Plant Equipment | 590.983 M | 662.170 M | 691.055 M | 706.840 M | 706.020 M | 765.037 M | 762.530 M | 717.765 M | |
| Other Assets | 221.325 M | 328.948 M | 276.778 M | 282.070 M | 247.517 M | 195.640 M | 197.215 M | 219.127 M | |
| Intangible Assets | 551.587 M | 544.796 M | 585.021 M | 570.192 M | 542.604 M | 526.821 M | 502.006 M | 345.456 M | |
| Goodwill | 2.299 B | 2.353 B | 2.454 B | 2.457 B | 2.434 B | 2.476 B | 2.449 B | 2.449 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 6.517 B | 6.288 B | 6.279 B | 6.347 B | 5.907 B | 6.115 B | 5.806 B | 5.585 B | |
| Total liabilities | 3.189 B | 2.821 B | 2.718 B | 2.724 B | 2.213 B | 2.307 B | 2.206 B | 2.179 B | |
| Total current liabilities | 1.498 B | 974.523 M | 890.244 M | 978.450 M | 524.371 M | 1.079 B | 1.025 B | 1.035 B | |
| Accounts Payable | 82.836 M | 98.734 M | 84.386 M | 83.939 M | 76.887 M | 84.155 M | 75.329 M | 76.061 M | |
| Other liabilities | 258.726 M | 374.703 M | 340.827 M | 357.273 M | 306.268 M | 306.309 M | 268.320 M | 235.545 M | |
| Current long term debt | 866.040 M | 389.552 M | 393.243 M | 500.149 M | 100.608 M | 587.970 M | 590.523 M | 492.699 M | |
| Long term debt | 1.423 B | 1.472 B | 1.487 B | 1.388 B | 1.382 B | 921.824 M | 912.814 M | 908.920 M | |
| Other liabilities | 258.726 M | 374.703 M | 340.827 M | 357.273 M | 306.268 M | 306.309 M | 268.320 M | 235.545 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.328 B | 3.467 B | 3.561 B | 3.624 B | 3.694 B | 3.808 B | 3.600 B | 3.405 B | |
| Common stock | 227.753 M | 227.767 M | 227.894 M | 228.160 M | 228.258 M | 228.272 M | 223.835 M | 221.989 M | |
| Retained earnings | 2.073 B | 2.160 B | 2.215 B | 2.283 B | 2.361 B | 2.457 B | 2.486 B | 2.265 B |